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Abstract
It has recently been shown that in a Buruli ulcer (BU) endemic region of southeastern Australia, significant numbers of
possums (native tree-dwelling marsupials) have clinical BU disease. Furthermore, based on quantitative PCR (qPCR) analysis,
animals with BU lesions (and some without) shed M. ulcerans DNA in their faeces, indicative of bacterial loads of up to 10
8
organisms/gram. These findings led us to propose that humans might also harbour M. ulcerans in their gastrointestinal tract
and shed the bacterium in their faeces. We conducted a pilot study and collected faecal swabs from 26 patients with
confirmed BU and 31 healthy household controls. Faecal samples were also collected from 10 healthy controls from non-
endemic regions in Ghana. All 67 specimens were negative when tested by IS2404 PCR. The detection sensitivity of this
method was $10
4 bacteria per gram (wet-weight) of human faecal material. We conclude that the human gastrointestinal
tract is unlikely to be a significant reservoir of M. ulcerans.
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Introduction
Efforts to control the spread of Buruli ulcer (BU) will be
significantly improved if we understand the ecology of the causative
agent, Mycobacterium ulcerans. Recent surveys of the environment in
BU endemic regions near Melbourne, Australia, have revealed that
over 40% of possums (small tree-dwelling animals native to
Australia with a body temperature like humans of ,36uC) are
shedding high levels of M. ulcerans DNA in their faeces and may be
acting as reservoirs of M. ulcerans [1]. A transmission model is
proposed where contaminated possum excreta enters mosquito
breeding habitats (drains and roof gutters near houses) where the
insects may acquire the bacterium and then transmit it to humans
during biting [2,3]. There are no possums in Africa and a recent
survey of small animals in Benin did not identify any species with M.
ulcerans intheir organsorfaeces[4].Nevertheless,the presenceofM.
ulcerans in the gastrointestinal tract of warm-blooded, terrestrial
animals has led to a reconsideration ofwhere M. ulcerans is located in
the environment, and raises the possibility of a terrestrial animal
reservoir for the bacterium in African BU endemic regions. We
therefore speculated that humans were acting like the possums - as
both a disease-susceptible host and possible reservoir. To test this
hypothesis we used IS2404 qPCR to screen faecal specimens from
confirmed BU patients, household contacts, and control samples




Tepa Government Hospital, Ahafo North District and Komfo
Anokye Teaching Hospital Hospital, Kumasi.
Clinical specimen collection
In this pilot study, we assembled a convenience sample of
patients and accompanying unaffected household members who
were attending a Buruli treatment clinic. Patients and controls
were recruited by local health workers in villages near Tepa
Government Hospital in the Ashanti region of Ghana where there
is a high prevalence of M. ulcerans disease. All patients enrolled in
this study met the WHO case definition for BU. Non-endemic
control subjects were recruited from villages where BU has never
been reported. Relevant details for patients and controls are
summarized in Tables 1, 2, 3. Fine needle aspirates and swab
specimens were taken from patients to confirm the clinical
diagnosis by IS2404 PCR. Patients were then treated with
10 mg/kg oral rifampicin and 15 mg/kg intramuscular strepto-
mycin combination daily for 8 weeks (SR8), administered at village
health posts. Faecal samples were collected in sterile 50 ml BD
plaster containers and transported cold to the laboratory at the
Komfo Anokye Teaching Hospital and stored at 4uC. For four BU
patients, faecal samples were obtained during antibiotic treatment.
Swabs of faecal samples were subsequently shipped to the WHO
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detection and quantification of M. ulcerans by qPCR.
Faecal spiking experiment
In an experiment to mimic testing swabs of human faecal
material, five equal aliquots of human faeces (partially liquefied by
the addition of water to aid homogenization) were spiked with a 10-
fold dilution series of M. ulcerans equivalent to 3.2610
5 organisms
per gram, and a sixth aliquot was included as an unspiked control.
Bacterial numbers were estimated based on the turbidity of the
initial suspension, which was equivalent to a MacFarlane Standard
of 1. Sterile swabs were used to transfer spiked faecal material to
glass bead bottles containing 2 ml of phosphate buffered saline
(PBS). Weighing tubes containing the spiked faecal samples before
and after swabbing indicated an average 40 mg (range: 30–60 mg)
of faecal material was transferred by this technique. M ulcerans DNA
was extracted as described below.
Quantitative PCR analysis
DNA was extracted from faecal samples using the FastDNAH
SPIN Kit for Soil and FastPrepH Instrument (Qbiogene Inc.,
Carlsbad, CA) in combination with the QIAxtractor Instrument
(QIAGEN Pty Ltd, Doncaster, Victoria, Australia). Swab ends were
placed in sterile bead bottles with 2 ml of phosphate buffered saline
(PBS) and vortexed vigorously for 2 minutes. One millilitre of
sample was transferred to Lysing Matrix E tubes and centrifuged at
16,0006g for 10 mins. The supernatant was removed and samples
were processed according to the FastDNAH SPIN Kit for Soil
protocol with the following modification. After the Protein
Precipitating Solution (PPS) was added to the lysate and the
samples were centrifuged, 200 ml of sample was added to the
QIAxtractor Instrument and purified using the QIAxtractor Liquid
Sample Protocol. To exclude the possibility of cross-contamination,
at least one negative control was included in every DNA extraction.
DNA extracts were tested for the presence of M. ulcerans DNA using
a TaqMan real-time PCR assay targeting IS2404 as described
previously [5]. The assay is multiplexed with an internal positive
control (IPC) to monitor PCR inhibition and control for false
negative results. Two positive controls and four negative (no
template) controls were included in every real-time PCR assay to
ensure the test results were valid. Laboratory technicians were not
aware of the origin of the samples they were testing.
Ethics statement
The Committee on Human Research, Publication and Ethics
(CHRPE) at the School of Medical Sciences, Kwame Nkrumah










M101 6 weeks, STR* M 10 Asutifi E/IIII IS2404 PCR +
M107 2 weeks, STR M 11 Ahafo Ano North E/III IS2404 PCR +
M101 6 weeks, STR M 10 Asutifi E/III IS2404 PCR +
M102 4 weeks, STR M 32 Ahafo Ano North N/I IS2404 PCR +
M98 None M 60 Asutifi U/II IS2404 PCR +, Culture +
M104 None M 13 Asutifi U/II IS2404 PCR +
M105 None M 11 Ahafo Ano North E/III IS2404 PCR +
M107 None F 13 Ahafo Ano North U/III IS2404 PCR +
M110 None M 2 Ahafo Ano North N/I IS2404 PCR +
M111 None M 29 Asutifi Q/II IS2404 PCR +
M112 None F 20 Asutifi U/II IS2404 PCR +
M113 None F 3 Ahafo Ano North E/II IS2404 PCR +
M116 None F 37 Ahafo Ano North N/I IS2404 PCR +
M119 None M 14 Ahafo Ano North N/I IS2404 PCR +
M121 None M 16 Ahafo Ano North U/II IS2404 PCR +
M123 None F 9 Ahafo Ano North U/I IS2404 PCR +
M124 None F Un-known Tano North U/III IS2404 PCR +, Culture +,Z N +
M126 None M 14 Ahafo Ano North U/III IS2404 PCR +
M127 None F 32 Tano North U/III IS2404 PCR +, Culture +,Z N+
M128 None M 3 Asutifi U/III IS2404 PCR +
M129 None M 18 Asutifi E/III IS2404 PCR +
M131 None M 8 Asutifi Q/II IS2404 PCR +
M132 None M 11 Asutifi E/III IS2404 PCR +
M133 None M 34 Ahafo Ano North U/III IS2404 PCR +
M84 None F 10 Ahafo Ano North U/II IS2404 PCR +
M96 None F 1 Tano North U/III IS2404 PCR +
*STR=WHO recommended treatment of 8 weeks streptomycin and rifampicin;
#‘Category’ refers to WHO clinical severity scoring system for BU E=edematous, N=nodule, Q=Plaque, U=ulcerative.
doi:10.1371/journal.pone.0019611.t001
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the study protocol. Informed, written consent was obtained from
all participants or their legal guardians as approved by the
CHRPE.
Results
Prior to PCR screening of human faecal material we
established the detection sensitivity of DNA extraction and
IS2404 qPCR analysis method. Spiking experiments with serial
10-fold dilutions of M. ulcerans in human faeces showed that the
smallest inoculum of M. ulcerans that was readily detected by
IS2404 qPCR was 1.2610
3 bacterial cells per swab (Fig. 1),
which represents an overall minimum detection limit $3610
4 M.
ulcerans per gram wet faecal material. PCR inhibitors were
effectively removed by this DNA extraction method as the IPC
was readily detected in DNA extracted from all dilutions of spiked
faecal material (Figure 1).
Having established a robust molecular detection assay, faecal
swabs were collected from 26 PCR-confirmed BU patients (age
range 2–37 years, 17 male subjects & 9 female subjects) and 31
healthy household contacts (age range 3–82 years, 13 male
subjects & 18 female subjects) (Tables 1, 2). The patients and
contacts came from two BU endemic regions in Ghana (Ashanti
and Brong Ahafo districts). Faecal swabs were also collected from
10 healthy controls from nine non-endemic regions in Ghana
(age range 8–30 years, 7 male subjects & 3 female subjects)
(Table 3). Four of the 26 BU patients had commenced SR8 at
the time of sample collection. None of the other study
participants were on any antimicrobial treatment. Clinical
presentation among the patient cohort encompassed the
spectrum of BU with the exception of bone involvement
(Table 1, Figure 2). Total DNA was extracted from all 67
specimens and tested by IS2404 qPCR. All 67 samples were
IS2404 PCR negative. Based on our assessments of assay
sensitivity, this indicates there were ,10
4 M. ulcerans per gram
faecal material. The results are not explained by PCR inhibition
as the internal positive control was amplified from each of the 67
samples at a cycle threshold value equivalent to that obtained in
both positive and negative controls.
Table 2. Details for household contacts enrolled in the study.
Ref. No. Sex Age Endemic District
9 M 3 Asutifi
18 M 8 Asutifi
19 F Unknown Tano North
29 M 8 Asutifi
41 M 18 Asutifi
42 F 13 Asutifi
44 F 16 Ahafo Ano North
45 F 23 Asutifi
50 M 14 Asutifi
51 M 11 Asutifi
53 F 13 Ahafo Ano North
56 F 32 Tano North
64 M 14 Ahafo Ano North
66 M 16 Ahafo Ano North
68 F 13 Ahafo Ano North
57 M 17 Ahafo Ano North
32 F 40 Ahafo Ano North
43 F 14 Ahafo Ano North
34 M 16 Tano North
47 F 36 Ahafo Ano North
36 F 82 Tano North
59 F 14 Asutifi
35 M 45 Asutifi
67 F 15 Asutifi
69 M 32 Asutifi
61 F 19 Ahafo Ano North
39 F 23 Ahafo Ano North
40 F 82 Tano North
33 F 5 Asutifi
37 F 24 Ahafo Ano North
38 M 46 Ahafo Ano North
doi:10.1371/journal.pone.0019611.t002
Table 3. Details for non-exposed controls enrolled in the
study.
Ref. No. Sex Age District
82 F 16 Asafo
83 M 14 Asuoyeboa
84 M 26 Brofoyedu
85 F 29 Anyinam
86 M 15 Asouase
87 M 17 Suame
88 M 28 New Tafo
89 F 30 Santasi
90 M 13 Asafo
91 M 8 Bantama
doi:10.1371/journal.pone.0019611.t003
Figure 1. Results of spiking experiment, showing sensitivity of
IS2404 qPCR for the detection of M. ulcerans in human faecal
material. Depicted is the mean and standard deviation of duplicate
samples. IPC: Internal Positive Control.
doi:10.1371/journal.pone.0019611.g001
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The data collected in this pilot study suggest that, unlike
possums in a BU endemic area (which may shed up to 10
8
organisms per gram of faeces), humans do not shed detectable
levels of M. ulcerans in their faeces. Nevertheless, even though
humans do not appear to carry M. ulcerans in their gastrointestinal
tracts, they may act as a susceptible host and a reservoir of M.
ulcerans. With the exception of possums in Australia, human BU
lesions represent the highest concentration of M. ulcerans cells in
any source identified so far. Bacteria from human BU lesions may
be shed into the environment by various means, such as household
fomite contamination, shedding into waterways during bathing of
lesions and/or disseminated by insects. High resolution molecular
epidemiological analysis of strains from the Densu River Basin in
Ghana suggest that transmission of M. ulcerans occurs at a very
local level, consistent with a local reservoir of the bacterium [6].
Furthermore, a recent study in Benin of the seroepidemiological
potential of M. ulcerans antigens suggested that there is widespread
exposure to M. ulcerans in BU endemic areas, again consistent with
a significant local reservoir of the bacterium in close contact with
humans [7].
This investigation suggests that humans are unlikely to carry M.
ulcerans in significant quantities in their gastrointestinal tracts.
However, it is also important to recognize that this is a pilot study
with only 26 BU patients enrolled by convenience from two
endemic foci in Ghana. Studies of a larger and randomly selected
patient/control cohort, within and between different BU endemic
countries, and across all manifestations of BU are now warranted.
While it is possible that human BU lesions themselves could be a
major indirect source of new human infections, the search should
also continue for another animal source of M. ulcerans in Africa like
possums in southern Australia.
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